NO20063134L - Mikrokrystaller og farmasoytiske formuleringer omfattende de samme - Google Patents

Mikrokrystaller og farmasoytiske formuleringer omfattende de samme

Info

Publication number
NO20063134L
NO20063134L NO20063134A NO20063134A NO20063134L NO 20063134 L NO20063134 L NO 20063134L NO 20063134 A NO20063134 A NO 20063134A NO 20063134 A NO20063134 A NO 20063134A NO 20063134 L NO20063134 L NO 20063134L
Authority
NO
Norway
Prior art keywords
microcrystals
same
pharmaceutical formulations
propaneamide
benzothiepin
Prior art date
Application number
NO20063134A
Other languages
English (en)
Norwegian (no)
Inventor
Norie Satoh
Naoto Izawa
Nobuhiro Yagi
Kazue Ouchi
Shoichi Narita
Noboru Aoki
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20063134L publication Critical patent/NO20063134L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
NO20063134A 2003-12-11 2006-07-06 Mikrokrystaller og farmasoytiske formuleringer omfattende de samme NO20063134L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003413725 2003-12-11
PCT/JP2004/018773 WO2005056561A1 (fr) 2003-12-11 2004-12-09 Preparation microcristalline et preparation medicinale contenant cette derniere

Publications (1)

Publication Number Publication Date
NO20063134L true NO20063134L (no) 2006-09-08

Family

ID=34675069

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063134A NO20063134L (no) 2003-12-11 2006-07-06 Mikrokrystaller og farmasoytiske formuleringer omfattende de samme

Country Status (13)

Country Link
US (1) US20070049634A1 (fr)
EP (1) EP1693374B1 (fr)
JP (1) JPWO2005056561A1 (fr)
KR (1) KR20060121163A (fr)
CN (1) CN1845927A (fr)
AT (1) ATE411320T1 (fr)
AU (1) AU2004297132A1 (fr)
CA (1) CA2550136A1 (fr)
DE (1) DE602004017220D1 (fr)
ES (1) ES2314484T3 (fr)
NO (1) NO20063134L (fr)
TW (1) TW200522943A (fr)
WO (1) WO2005056561A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019200065A1 (fr) 2018-04-11 2019-10-17 The Procter & Gamble Company Articles absorbants jetables

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002322B1 (ru) * 1997-04-15 2002-04-25 Киова Хакко Когио Ко., Лтд. Трициклические соединения
AU4531499A (en) * 1998-06-26 2000-01-17 Chugai Seiyaku Kabushiki Kaisha Fine powder of l-alpha-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders
JP2002053580A (ja) * 2000-08-09 2002-02-19 Kyowa Hakko Kogyo Co Ltd 三環系化合物の製造法
EP1318809A1 (fr) * 2000-08-14 2003-06-18 Teva Pharmaceutical Industries Ltd. Torsemide micronise
AU2002239504A1 (en) * 2000-12-06 2002-06-18 Pharmacia Corporation Laboratory scale milling process
KR20040007476A (ko) * 2001-03-30 2004-01-24 교와 핫꼬 고교 가부시끼가이샤 방광 과민증 치료제
KR20040007477A (ko) * 2001-03-30 2004-01-24 교와 핫꼬 고교 가부시끼가이샤 전립선 비대증과 연관된 방광 과민증 치료제
KR20040007482A (ko) * 2001-03-30 2004-01-24 교와 핫꼬 고교 가부시끼가이샤 방광 지각과민 치료제
JP4022519B2 (ja) * 2001-11-13 2007-12-19 協和醗酵工業株式会社 そう痒の予防または治療剤

Also Published As

Publication number Publication date
JPWO2005056561A1 (ja) 2007-07-05
CN1845927A (zh) 2006-10-11
TW200522943A (en) 2005-07-16
EP1693374B1 (fr) 2008-10-15
CA2550136A1 (fr) 2005-06-23
ES2314484T3 (es) 2009-03-16
KR20060121163A (ko) 2006-11-28
US20070049634A1 (en) 2007-03-01
DE602004017220D1 (de) 2008-11-27
EP1693374A1 (fr) 2006-08-23
WO2005056561A1 (fr) 2005-06-23
EP1693374A4 (fr) 2007-01-03
ATE411320T1 (de) 2008-10-15
AU2004297132A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
AU2003247668A1 (en) Non-irritating antiperspirant compositions containing acidic antiperspirant active
EP1420829A4 (fr) Compositions immunomodulatrices, preparations, et leurs procedes d'utilisation
AU2002234476A1 (en) Medical aerosol formulations
AU2002347910A1 (en) Methods and compositions for targeting proteins across the blood brain barrier
HK1087399A1 (en) Pharmaceutical formulations comprising highly purebases of 3, 3-giphenylpropylamine monoesters
EP1594544A4 (fr) Compositions orales de fenretinide a biodisponibilite accrue et leurs methodes d'utilisation
WO2002053519A3 (fr) Analogues de polyamine hydrophobe et procedes d'utilisation correspondants
AU2002248417A1 (en) Photoprotecting formulations
ZA200506750B (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluroanilino) phenylacetic acid
AU2002365647A1 (en) Pyridyloxyalkanoic acid amide derivatives useful as fungicides
HK1094152A1 (en) Orodispersible pharmaceutical composition of an antithrombotic compound
NO20063134L (no) Mikrokrystaller og farmasoytiske formuleringer omfattende de samme
IL160960A0 (en) Reduced toxicity cisplatin formulations and methods for using the same
WO2004048381A3 (fr) Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques
AU2002341145A1 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
AU2003224149A1 (en) N'-cyano-n-methyl-imidamide derivatives
AU2003216904A1 (en) Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
AU2002255698A1 (en) Substituted 3',4'-di-o-camphanoyl-(+)-cis-khellactone analogs,compositions thereof, and methods for using thereof
AU2002339720A1 (en) Improved pharmaceutical dental formulations
AU2003285261A1 (en) Compositions for the treatment of mycobacterial infections
AUPS123102A0 (en) Marker device (2)
AU2003303923A1 (en) Oral care composition comprising an antimicrobial agent
AU2002953460A0 (en) Dental formulation
AU2003281920A1 (en) Target-oriented formulations
WO2003069998A8 (fr) Compositions stables contenant de la tezacitabine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application